Sign in

CIK 0001815442

  • Large accelerated filer

Kymera Therapeutics, Inc.

Sign in to watch
Ticker
KYMR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812992166
Phone
+1 857-285-5314
Business address
500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
Former names
Kymera Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,158,214
in 2 filings, $3.4M under 10b5-1 plans

Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 68 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-02 Gollob Jared Chief Medical Officer Sale −297 $31.40 $9K 74,709
2023-03-02 Jacobs Bruce N. Chief Financial Officer Sale −1,056 $30.88 $33K 104,882
2023-03-02 Jacobs Bruce N. Chief Financial Officer Sale −314 $31.40 $10K 104,568
2023-03-01 Mainolfi Nello Chief Executive Officer Grant or award · Stock Option (Right to Buy) +450,000 450,000
2023-03-01 Caughey Elaine Chief Business Officer Grant or award +10,557 19,700
2023-03-01 Caughey Elaine Chief Business Officer Grant or award · Stock Option (Right to Buy) +63,338 63,338
2023-03-01 Gollob Jared Chief Medical Officer Grant or award +18,750 76,007
2023-03-01 Gollob Jared Chief Medical Officer Grant or award · Stock Option (Right to Buy) +112,500 112,500
2023-03-01 Jacobs Bruce N. Chief Financial Officer Grant or award +23,750 105,938
2023-03-01 Jacobs Bruce N. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +142,500 142,500
2023-01-12 Booth Bruce Director Sale −77,128 $30.29 $2.3M 4,968,114
2023-01-12 Booth Bruce Director Sale −21,592 $30.29 $654K 890,148
2023-01-12 Atlas Venture Fund X, L.P. 10% owner Sale −77,128 $30.29 $2.3M 4,968,114
2023-01-12 Atlas Venture Fund X, L.P. 10% owner Sale −21,592 $30.29 $654K 890,148
2023-01-12 BVF PARTNERS L P/IL Director Purchase +2,985 $31.24 $93K 2,494,688
2023-01-12 BVF PARTNERS L P/IL Director Purchase +15,912 $31.24 $497K 1,888,351
2023-01-11 Booth Bruce Director Sale −21,683 $29.96 $650K 5,045,242
2023-01-11 Booth Bruce Director Sale −6,071 $29.96 $182K 911,740
2023-01-11 Atlas Venture Fund X, L.P. 10% owner Sale −21,683 $29.96 $650K 5,045,242
2023-01-11 Atlas Venture Fund X, L.P. 10% owner Sale −6,071 $29.96 $182K 911,740

Page 33 of 41 · 810 trades